CardioVia

CardioVia Overview

CardioVia is a medical device company developing a system called ViaOne. ViaOne allows minimally invasive access to the outer surface of the heart (the pericardial space), which has been recognized as a promising entry route to treat prevalent cardiovascular diseases such as tamponade, effusion, and arrhythmias. ViaOne is intended to ensure safe pericardial access in order to avoid complications and ensure procedural success. It aims to increase the physicians confidence during the procedure while providing safety and assurance to the patient. The companys technology ensures that no needle is exposed to the heart at any time. The procedure is performed in a controlled and measured manner while synchronizing with the heartbeats, and the system allows penetration to the outer surface of the pericardial space without risk of puncturing the heart muscle. CardioVia established a complete operating system in preclinical studies and is currently in the process of receiving regulatory approvals from the FDA and CE. In addition, the project has received funding from the European Unions Horizon 2020 research and innovation program under grant agreement number 868213.

Cumulative Funding Raised Over Time ($)

Latest News

Apr 8, 2025 · www.prnewswire.com

growth-positive

/PRNewswire/ -- CardioVia, an innovative medical device company specializing in advanced cardiac care solutions, announced today that it has received U.S. Food...

CardioVia, a medical device company based in Tel Aviv, Israel, has received FDA clearance for its ViaOne system, a breakthrough device designed for safe and precise access to the hearts surface for diagnostic and therapeutic interventions. The ViaOne system eliminates the need for an exposed needle, reducing the risk of heart perforation. Recognized as a Breakthrough Medical Device by the FDA, ViaOne is set to redefine cardiac interventions by offering a safer and more efficient alternative to conventional methods. CardioVia plans to launch ViaOne commercially in leading cardiac centers across the United States, aiming to expand its availability and improve patient outcomes.

Product StageFDA approved/pending approval

Funding

Team Members

5

Employees: 1-10

Web & Social Links

Locations

Shpinoza Street 12, Tel Aviv-Yafo, Israel

Gordon Street 16, Tel Aviv-Yafo, Israel

Photos & Videos

5 item(s)

CardioVia Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info